GO:0003824 | catalytic activity | 51.02% (25/49) | 1.55 | 0.0 | 1.3e-05 |
GO:0016491 | oxidoreductase activity | 24.49% (12/49) | 2.61 | 0.0 | 3e-05 |
GO:0055114 | oxidation-reduction process | 22.45% (11/49) | 2.53 | 2e-06 | 0.000112 |
GO:0003674 | molecular_function | 63.27% (31/49) | 0.92 | 1.8e-05 | 0.000612 |
GO:0048037 | cofactor binding | 16.33% (8/49) | 2.8 | 1.6e-05 | 0.000681 |
GO:0050662 | coenzyme binding | 12.24% (6/49) | 2.92 | 0.00013 | 0.003614 |
GO:0030145 | manganese ion binding | 4.08% (2/49) | 5.79 | 0.000554 | 0.013219 |
GO:0043169 | cation binding | 16.33% (8/49) | 1.98 | 0.000826 | 0.013801 |
GO:0004177 | aminopeptidase activity | 4.08% (2/49) | 5.62 | 0.00071 | 0.014828 |
GO:0046872 | metal ion binding | 16.33% (8/49) | 1.98 | 0.000803 | 0.014892 |
GO:0043167 | ion binding | 26.53% (13/49) | 1.33 | 0.001305 | 0.019818 |
GO:0046102 | inosine metabolic process | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0006559 | L-phenylalanine catabolic process | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0043101 | purine-containing compound salvage | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0004411 | homogentisate 1,2-dioxygenase activity | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0043094 | cellular metabolic compound salvage | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0008253 | 5'-nucleotidase activity | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0050483 | IMP 5'-nucleotidase activity | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0043174 | nucleoside salvage | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0006190 | inosine salvage | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0004334 | fumarylacetoacetase activity | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0046103 | inosine biosynthetic process | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:1902222 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0008252 | nucleotidase activity | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0006166 | purine ribonucleoside salvage | 2.04% (1/49) | 7.79 | 0.004534 | 0.022943 |
GO:0006082 | organic acid metabolic process | 8.16% (4/49) | 2.9 | 0.001959 | 0.023364 |
GO:0019752 | carboxylic acid metabolic process | 8.16% (4/49) | 2.93 | 0.00184 | 0.023633 |
GO:0043436 | oxoacid metabolic process | 8.16% (4/49) | 2.93 | 0.00184 | 0.023633 |
GO:0036094 | small molecule binding | 18.37% (9/49) | 1.45 | 0.004882 | 0.02398 |
GO:0044281 | small molecule metabolic process | 10.2% (5/49) | 2.4 | 0.002462 | 0.0257 |
GO:0008238 | exopeptidase activity | 4.08% (2/49) | 4.79 | 0.00232 | 0.025833 |
GO:0000287 | magnesium ion binding | 4.08% (2/49) | 4.08 | 0.006105 | 0.029131 |
GO:0016787 | hydrolase activity | 16.33% (8/49) | 1.5 | 0.006509 | 0.030194 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 4.08% (2/49) | 3.98 | 0.00706 | 0.031866 |
GO:0042278 | purine nucleoside metabolic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0042451 | purine nucleoside biosynthetic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0042455 | ribonucleoside biosynthetic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0009163 | nucleoside biosynthetic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0009119 | ribonucleoside metabolic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0046129 | purine ribonucleoside biosynthetic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0046128 | purine ribonucleoside metabolic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0009074 | aromatic amino acid family catabolic process | 2.04% (1/49) | 6.79 | 0.009047 | 0.032147 |
GO:0009072 | aromatic amino acid family metabolic process | 4.08% (2/49) | 4.54 | 0.003278 | 0.0322 |
GO:0006520 | cellular amino acid metabolic process | 6.12% (3/49) | 2.91 | 0.007336 | 0.032238 |
GO:0051287 | NAD binding | 4.08% (2/49) | 3.83 | 0.00861 | 0.03687 |
GO:1901606 | alpha-amino acid catabolic process | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:0006558 | L-phenylalanine metabolic process | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:1901659 | glycosyl compound biosynthetic process | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:1902221 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:0006570 | tyrosine metabolic process | 2.04% (1/49) | 6.2 | 0.013541 | 0.041876 |
GO:0070011 | peptidase activity, acting on L-amino acid peptides | 6.12% (3/49) | 2.56 | 0.014126 | 0.042892 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.08% (2/49) | 3.43 | 0.014753 | 0.043997 |
GO:0005488 | binding | 32.65% (16/49) | 0.81 | 0.012985 | 0.045176 |
GO:0008233 | peptidase activity | 6.12% (3/49) | 2.51 | 0.015513 | 0.045449 |
GO:0016054 | organic acid catabolic process | 2.04% (1/49) | 5.79 | 0.018014 | 0.048522 |
GO:0042737 | drug catabolic process | 2.04% (1/49) | 5.79 | 0.018014 | 0.048522 |
GO:0046395 | carboxylic acid catabolic process | 2.04% (1/49) | 5.79 | 0.018014 | 0.048522 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 2.04% (1/49) | 5.79 | 0.018014 | 0.048522 |
GO:0009063 | cellular amino acid catabolic process | 2.04% (1/49) | 5.79 | 0.018014 | 0.048522 |
GO:0046914 | transition metal ion binding | 10.2% (5/49) | 1.69 | 0.018804 | 0.049845 |